Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Trisomy 15, sex chromosome loss, and hematological malignancy.
Baumgartner BJ, Shurafa M, Terebelo H, Tapazoglou E, Van Dyke DL. Baumgartner BJ, et al. Among authors: tapazoglou e. Cancer Genet Cytogenet. 2000 Mar;117(2):132-5. doi: 10.1016/s0165-4608(99)00163-6. Cancer Genet Cytogenet. 2000. PMID: 10704683
Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
Hesketh P, Navari R, Grote T, Gralla R, Hainsworth J, Kris M, Anthony L, Khojasteh A, Tapazoglou E, Benedict C, Hahne W. Hesketh P, et al. Among authors: tapazoglou e. J Clin Oncol. 1996 Aug;14(8):2242-9. doi: 10.1200/JCO.1996.14.8.2242. J Clin Oncol. 1996. PMID: 8708713 Clinical Trial.
26 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page